Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−3.55 HKD
−933.13 M HKD
139.15 M HKD
187.74 M
About EVEREST MEDICINES LTD
Sector
CEO
Yong Qing Luo
Headquarters
Shanghai
Website
Founded
2017
FIGI
BBG00XJ8RXX1
Everest Medicines Ltd. is a biopharmaceutical company, which engages in the discovering, developing, manufacturing, and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Asian markets. Its therapeutic areas of interest include oncology, autoimmune disorders, cardio-renal diseases, and infectious diseases. The company was founded on July 14, 2017 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1952 is 46.50 HKD — it has decreased by −0.75% in the past 24 hours. Watch EVEREST MEDICINES LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange EVEREST MEDICINES LTD stocks are traded under the ticker 1952.
1952 stock has fallen by −3.93% compared to the previous week, the month change is a 26.02% rise, over the last year EVEREST MEDICINES LTD has showed a 142.95% increase.
We've gathered analysts' opinions on EVEREST MEDICINES LTD future price: according to them, 1952 price has a max estimate of 56.19 HKD and a min estimate of 54.99 HKD. Watch 1952 chart and read a more detailed EVEREST MEDICINES LTD stock forecast: see what analysts think of EVEREST MEDICINES LTD and suggest that you do with its stocks.
1952 reached its all-time high on Feb 17, 2021 with the price of 104.80 HKD, and its all-time low was 6.00 HKD and was reached on Oct 25, 2022. View more price dynamics on 1952 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
1952 stock is 3.35% volatile and has beta coefficient of 0.81. Track EVEREST MEDICINES LTD stock price on the chart and check out the list of the most volatile stocks — is EVEREST MEDICINES LTD there?
Today EVEREST MEDICINES LTD has the market capitalization of 15.16 B, it has increased by 6.18% over the last week.
Yes, you can track EVEREST MEDICINES LTD financials in yearly and quarterly reports right on TradingView.
EVEREST MEDICINES LTD is going to release the next earnings report on Mar 27, 2025. Keep track of upcoming events with our Earnings Calendar.
1952 earnings for the last half-year are −2.12 HKD per share, whereas the estimation was −1.09 HKD, resulting in a −95.05% surprise. The estimated earnings for the next half-year are −1.13 HKD per share. See more details about EVEREST MEDICINES LTD earnings.
EVEREST MEDICINES LTD revenue for the last half-year amounts to 323.96 M HKD, despite the estimated figure of 271.54 M HKD. In the next half-year revenue is expected to reach 439.88 M HKD.
1952 net income for the last half-year is −685.30 M HKD, while the previous report showed −454.66 M HKD of net income which accounts for −50.73% change. Track more EVEREST MEDICINES LTD financial stats to get the full picture.
No, 1952 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 432.00 employees. See our rating of the largest employees — is EVEREST MEDICINES LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EVEREST MEDICINES LTD EBITDA is −676.30 M HKD, and current EBITDA margin is −610.12%. See more stats in EVEREST MEDICINES LTD financial statements.
Like other stocks, 1952 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EVEREST MEDICINES LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EVEREST MEDICINES LTD technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EVEREST MEDICINES LTD stock shows the strong buy signal. See more of EVEREST MEDICINES LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.